TET 蛋白,包括 TET1、TET2 和 TET3,是一类参与 DNA 去甲基化的双氧化酶家族。它们通过催化5-甲基胞嘧啶(5mC)转化为5-羟甲基胞嘧啶(5hmC)、5-甲酰基胞嘧啶(5fC)和 5-羧基胞嘧啶(5caC),促进 DNA 去甲基化。这些酶在其 C 端共享一个共同的核心催化域。TET3 在卵细胞和受精卵中表达丰富,但在分裂过程中迅速消失,而 TET1 和 TET2 在着床前发育过程中表达增加。TET1 对于发育和肠道干细胞功能至关重要。TET2 的突变在血液学恶性肿瘤中频繁出现,如骨髓增生异常综合征和急性髓系白血病。TET3 在多种生物过程中的去甲基化中发挥重要作用,包括受精卵形成、胚胎发生、轴突再生和突触传递[1][2]。
TET proteins, including TET1, TET2, and TET3, are a family of dioxygenases that catalyze the demethylation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC), facilitating DNA demethylation. These enzymes share a common core catalytic domain at their C termini. TET3 is highly expressed in oocytes and fertilized zygotes but decreases during cleavage, while TET1 and TET2 expression increases during pre-implantation development. TET1 is crucial for development and intestinal stem cell function. TET2 mutations are frequently found in hematologic malignancies, such as myelodysplastic syndrome and acute myeloid leukemia. TET3 plays a significant role in demethylation processes, including zygote formation, embryogenesis, axon regeneration, and synaptic transmission[1][2].
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号